Results 191 to 200 of about 77,771 (318)

Structure and sequence evolution in the pennycress (Thlaspi arvense) pangenome

open access: yesNew Phytologist, Volume 250, Issue 5, Page 2723-2741, June 2026.
Summary Eukaryotic genomes harbor many forms of variation, including nucleotide diversity and structural polymorphisms, which experience natural selection and contribute to genome evolution and biodiversity. Harnessing this variation for agriculture hinges on our ability to detect, quantify, catalog, and deploy genetic diversity. Here, we explore seven
Kevin A. Bird   +25 more
wiley   +1 more source

The Telomere-Binding Protein Taz1p as a Target for Modification by a SUMO-1 Homologue in Fission Yeast

open access: green, 2005
Karen G. Spink   +4 more
openalex   +2 more sources

The telomere-binding protein Rif2 and ATP-bound Rad50 have opposing roles in the activation of yeast Tel1ATM kinase [PDF]

open access: hybrid, 2019
Sarem Hailemariam   +5 more
openalex   +1 more source

Characterizing telomere-binding protein Hmbox1a/b and Zbtb48 in zebrafish

open access: yes
Telomeres are nucleoprotein structures at the ends of linear chromosomes, bound by various proteins. Some of these proteins protect the telomere ends, such as the shelterin complex, while others help regulate telomere length. Recently, our lab has characterized two telomere-binding proteins, HMBOX1 and ZBTB48, in mammalian cell lines.
openaire   +2 more sources

Regulated Cell Death in Idiopathic Pulmonary Fibrosis

open access: yesThe FASEB Journal, Volume 40, Issue 9, 15 May 2026.
This graphical abstract illustrates regulated cell death (RCD) across key pulmonary cell types—including alveolar epithelial cells, fibroblasts, macrophages, and endothelial cells—modulated through a dynamic death modulation network within the IPF microenvironment.
Xiaoyue Pan   +10 more
wiley   +1 more source

Evolution of Telomeres in Schizosaccharomyces pombe and Its Possible Relationship to the Diversification of Telomere Binding Proteins. [PDF]

open access: yesPLoS One, 2016
Sepsiova R   +8 more
europepmc   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

open access: yesMolecular Oncology, Volume 20, Issue 5, Page 1284-1298, May 2026.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy